Finally, older individuals and those with comorbidities such as cancer, chronic infections or prior exposure to immunotherapy are underrepresented in existing datasets, yet these groups are highly relevant to real-world sepsis and may respond differently to CD8+ T cell-targeted therapies. This evidence concerns the gene CD8A and cancer.